NRNP 6568
NRNP 6568 Week 7 Knowledge Check Exam Updated 2026
• Question 1
1 out of 1 points
Alopecia of outer one third of eyebrow and myxedema is are symptoms of:
Selected
Answer: Hypothyroidism
Answers: Hyperthyroidis m
Thyroid CA
Hypothyroidi
sm
Thyrotoxicos
• Question 2
is
1 out of 1 points
Insulin doses typically remain the same when a woman with Type 1 Diabetes Mellitus
becomes pregnant. True or False?
Selected
Answer: Fals e
Answers: True
Fals e
NRNP 6568
, NRNP 6568
• Question 3
1 out of 1 points
What are the primary purpose of periodic examination of patients with known
Diabetes Mellitus?
Selected
Answer: evaluate blood glucose control; to assess for end-organ damage; to assess
for associated diseases
Answers:
evaluate blood glucose control; to assess for end-organ damage; to
assess for associated diseases
reverse end organ damage, prevent renal dysfunction, escalate drug
therapy
wean off diabetic medications to prevent tolerance, reverse end organ
damage, evaluate blood glucose control
reverse end organ damage, escalate drug therapy, meet quality
reporting requirements
NRNP 6568
NRNP 6568 Week 7 Knowledge Check Exam Updated 2026
• Question 1
1 out of 1 points
Alopecia of outer one third of eyebrow and myxedema is are symptoms of:
Selected
Answer: Hypothyroidism
Answers: Hyperthyroidis m
Thyroid CA
Hypothyroidi
sm
Thyrotoxicos
• Question 2
is
1 out of 1 points
Insulin doses typically remain the same when a woman with Type 1 Diabetes Mellitus
becomes pregnant. True or False?
Selected
Answer: Fals e
Answers: True
Fals e
NRNP 6568
, NRNP 6568
• Question 3
1 out of 1 points
What are the primary purpose of periodic examination of patients with known
Diabetes Mellitus?
Selected
Answer: evaluate blood glucose control; to assess for end-organ damage; to assess
for associated diseases
Answers:
evaluate blood glucose control; to assess for end-organ damage; to
assess for associated diseases
reverse end organ damage, prevent renal dysfunction, escalate drug
therapy
wean off diabetic medications to prevent tolerance, reverse end organ
damage, evaluate blood glucose control
reverse end organ damage, escalate drug therapy, meet quality
reporting requirements
NRNP 6568
